How to handle prostate cancer recurrence Prostate cancer recurrence is the most common question we receive here at the Prostate Cancer Awareness Project. Unfortunately, there is no simple answer. The chances of your prostate cancer returning depend on your particular prostate cancer and the circumstances of your diagnosis and treatment. The article below, from the Harvard prostate knowledge center, provides a great deal of insight. I found it personally very helpful. Marc B. Garnick, M.D., discusses what biochemical recurrence means and what your options are “Am I going to die?” This is the first question a patient usually asks me when a follow-up blood test reveals that his prostate-specific antigen (PSA) level has risen after he has already undergone treatment for prostate cancer (usually a radical prostatectomy or radiation therapy). The fear is understandable: When PSA levels rise to a certain threshold after prostate cancer treatment, the patient has suffered what is known technically as a biochemical recurrence, sometimes also referred to as a biochemical relapse or stage D1.5 disease. Whatever term is used, it means that prostate cancer remains within the prostate after radiation therapy, that it survived outside the excised area after radical prostatectomy, or that it […] read more 
How to handle prostate cancer recurrence
How to handle prostate cancer recurrence Prostate cancer recurrence is the most common question we receive here at the Prostate Cancer Awareness Project. Unfortunately, there is no simple answer. The chances of your prostate cancer returning depend on your particular prostate cancer and the circumstances of your diagnosis and treatment. The article below, from the Harvard prostate knowledge center, provides a great deal of insight. I found it personally very helpful. Marc B. Garnick, M.D., discusses what biochemical recurrence means and what your options are “Am I going to die?” This is the first question a patient usually asks me when a follow-up blood test reveals that his prostate-specific antigen (PSA) level has risen after he has already undergone treatment for prostate cancer (usually a radical prostatectomy or radiation therapy). The fear is understandable: When PSA levels rise to a certain threshold after prostate cancer treatment, the patient has suffered what is known technically as a biochemical recurrence, sometimes also referred to as a biochemical relapse or stage D1.5 disease. Whatever term is used, it means that prostate cancer remains within the prostate after radiation therapy, that it survived outside the excised area after radical prostatectomy, or that it […] read more How Spy Thriller Author Vince Flynn Succumbed to a Silent Killer
Spy Thriller Author Vince Flynn Dead at Age 47 – of Prostate Cancer! by Robert Warren Hess We learned last week that espionage thriller author Vince Flynn died on June 19, 2013, of prostate cancer at age 47. News reports tell us that Flynn was diagnosed in 2010 at age 43 with Stage 3 prostate cancer. Flynn wrote the Mitch Rapp novels about the CIA, three of which reached the Number 2 slot on USA Today’s list of best sellers. Flynn’s diagnosis and death highlight several key points that were made by two doctors on Fox New’s Sunday morning medical show, Housecall . . . Prostate cancer is not an old man’s disease Prostate cancers that appear early generally are aggressive (30,000 men die every year from prostate cancer) It’s critical to get a baseline PSA test at 35 and watch for any changes from one year to the next How to Make Your Prostate Cancer Risk Visible The best early indicator of prostate cancer is the PSA (prostate specific antigen) test. The PSA test isn’t perfect, but it is a good indicator, especially if you track your PSA’s trend over time. A simple way to do this is with […] read more Donate to PCAP
Simply click the Donate Now button below to visit our site at the Network for Good. . .
Follow PCAP
Follow Pony Express
RSS Newsletter
If you would like to stay updated with all of our latest news please enter your e-mail address here.